Literature DB >> 2064402

Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective.

J M Dodson1, J DeSpain, J E Hewett, D P Clark.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2064402

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  21 in total

1.  TAT-mediated delivery of a DNA repair enzyme to skin cells rapidly initiates repair of UV-induced DNA damage.

Authors:  Jodi L Johnson; Brian C Lowell; Olga P Ryabinina; R Stephen Lloyd; Amanda K McCullough
Journal:  J Invest Dermatol       Date:  2010-10-07       Impact factor: 8.551

2.  Actinic keratoses: a comprehensive update.

Authors:  Sherrif F Ibrahim; Marc D Brown
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

3.  Long-term Follow up of Diclofenac Sodium 3% in 2.5% Hyaluronic Acid Gel for Actinic Keratosis: One-year Evaluation.

Authors:  Christopher Nelson; Darrell Rigel
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

4.  Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer.

Authors:  Joel L Cohen
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

Review 5.  [Actinic keratoses. Pathogenesis, clinical aspect and modern therapeutic options].

Authors:  T Strunk; R-M Szeimies
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

6.  No evidence of human papillomavirus DNA in actinic keratosis.

Authors:  S Lu; K Syrjänen; V K Havu
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 7.  [The aged scalp : A dermato-oncological focus point].

Authors:  N Wroblewski; K Wylon; C Ulrich
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

Review 8.  [Actinic keratoses].

Authors:  P Babilas; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2003-06       Impact factor: 0.751

Review 9.  [Actinic keratoses].

Authors:  T Hommel; R-M Szeimies
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

Review 10.  Pharmacoeconomic considerations in treating actinic keratosis.

Authors:  Marjorie V Neidecker; Mary Lynn Davis-Ajami; Rajesh Balkrishnan; Steven R Feldman
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.